Chu Caen Normandie
Caen, 14000, France
NCT Number: NCT05957497
The transport of biological samples is a key step in the pre-analysis process in health facilities and must meet quality requirements (NF:EN:ISO 151989) to ensure that samples are transported in are transported in good conditions.
Still in the experimental stage, drone-based air transport is participating in the aeronautical revolution of the development of unmanned aircraft on board in all areas of society, including health.
This first project, led by the Biology Centre and the INNOVABIO Biological Resources Centre of the CHU de CAEN in collaboration with the company Delivrone, will allow to evaluate the feasibility in real condition of the mode of transport by drone versus transport of reference on the quality of a varied panel of medical biology examinations (biochemistry, hematology and haemostasis), on the safety of people (potentially infectious samples), on the control of the delivery time, on the control of the transport temperature (15-25°C ). The samples will be taken on 30 healthy volunteers with a total panel of 23 blood tests performed.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Caen, 14000, France
Panel of blood tests performed on healthy volunteers samples include :
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Biological samples transport and analysis
Time frame: 1 day
Evaluation difference between results of Sodium (mmol/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of Potassium (mmol/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of Chlorure (mmol/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of Bicarbonate (mmol/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of Protein (g/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of Calcium (mmol/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of Creatinin (µmol/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of Urea (mmol/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of Albumin (g/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of Bilirubin (µmol/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of liver transaminase (ALT, U/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of liver transaminase (AST, U/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of alkalin phosphatase (U/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of GGT (U/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of LDH (U/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of C-reactive Protein (mg/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of red blood cells (T/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of hemoglobin (g/dL) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of white blood cells (G/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of neutrophil cells (G/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of lymphocytes cells (G/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of platelets (G/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of sedimentation rate (mm) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of PT (sec and %) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of a-PTT (sec) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of Fibrinogen (g/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Evaluation difference between results of D-Dimer (ng/mL) after drone transport (30 samples) versus pedestrian transport (30 samples).
Time frame: 1 day
Report accident of drone or users injuries
Time frame: 1 day
Report numbers of samples broken (contamination risk) after drone transport
Time frame: 1 day
Temperature measurement during the transport. Evaluation of the ambient temperature respect during the transport in the two conditions.
University Hospital, Caen
Other
Drone Biological Samples Transport Evaluation Compared to Walking in CHU CAEN NORMANDIE
Acronym: DBT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details